Photodiagnosis and Photodynamic Therapy, volume 29, pages 101568

Photodynamic therapy for atherosclerosis. The potential of Indocyanine Green.

Houthoofd Sabrina 1
Vuylsteke M. 2
Mordon S. 3
Fourneau Inge 1
2
 
Department of Vascular Surgery, Sint-Andriesziekenhuis, Tielt, Belgium.
3
 
INSERM U1189 - ONCO-THAI, Université Lille Nord de France, Lille, France.
Publication typeJournal Article
Publication date2020-03-01
Quartile SCImago
Q2
Quartile WOS
Q3
Impact factor3.3
ISSN15721000
Oncology
Biophysics
Pharmacology (medical)
Dermatology
Abstract
AIM The aim of this article is to summarize and review the use of photodynamic therapy for the treatment of atherosclerotic plaque and the prevention of intimal hyperplasia. Different photosensitizers are discussed and more specifically the role of indocyanine green as a potential photosensitizer. METHODS Literature search with focus on the use of photodynamic therapy in atherosclerosis, the mechanism of action and the different photosensitizers for photodynamic therapy. RESULTS In-vitro and in-vivo studies confirm the possibilities of using photodynamic therapy for the treatment of atherosclerosis and the prevention of restenosis. Insufficient specificity in the accumulation of photosensitizer and thus phototoxicity, remains an important problem. Indocyanine green is a photosensitizer with features in favor of photodynamic therapy. Results obtained so far of photodynamic therapy with indocyanine green point towards the potential of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis. CONCLUSION Photodynamic therapy is a promising tool for treating atherosclerosis. Many of the studied photosensitizers have toxic effects. Indocyanine green might be a good photosensitizer for the use of photodynamic therapy in atherosclerosis. These data justify further research to the use of indocyanine green as a photosensitizer in the treatment of atherosclerotic plaque both de novo or in restenotic lesions.

Citations by journals

1
2
3
4
5
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 5, 11.36%
International Journal of Molecular Sciences
5 publications, 11.36%
Pharmaceutics
Pharmaceutics, 4, 9.09%
Pharmaceutics
4 publications, 9.09%
ACS Applied Bio Materials
ACS Applied Bio Materials, 2, 4.55%
ACS Applied Bio Materials
2 publications, 4.55%
Photodiagnosis and Photodynamic Therapy
Photodiagnosis and Photodynamic Therapy, 2, 4.55%
Photodiagnosis and Photodynamic Therapy
2 publications, 4.55%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 2, 4.55%
International Journal of Biological Macromolecules
2 publications, 4.55%
Antioxidants
Antioxidants, 1, 2.27%
Antioxidants
1 publication, 2.27%
Biomedicines
Biomedicines, 1, 2.27%
Biomedicines
1 publication, 2.27%
Diagnostics
Diagnostics, 1, 2.27%
Diagnostics
1 publication, 2.27%
Frontiers in Pharmacology
Frontiers in Pharmacology, 1, 2.27%
Frontiers in Pharmacology
1 publication, 2.27%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 1, 2.27%
Frontiers in Bioengineering and Biotechnology
1 publication, 2.27%
Pharmaceuticals
Pharmaceuticals, 1, 2.27%
Pharmaceuticals
1 publication, 2.27%
Photochemical and Photobiological Sciences
Photochemical and Photobiological Sciences, 1, 2.27%
Photochemical and Photobiological Sciences
1 publication, 2.27%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 1, 2.27%
Journal of Nanobiotechnology
1 publication, 2.27%
Nano Research
Nano Research, 1, 2.27%
Nano Research
1 publication, 2.27%
Bioorganic Chemistry
Bioorganic Chemistry, 1, 2.27%
Bioorganic Chemistry
1 publication, 2.27%
Journal of Photochemistry and Photobiology B: Biology
Journal of Photochemistry and Photobiology B: Biology, 1, 2.27%
Journal of Photochemistry and Photobiology B: Biology
1 publication, 2.27%
Biomaterials
Biomaterials, 1, 2.27%
Biomaterials
1 publication, 2.27%
Polyhedron
Polyhedron, 1, 2.27%
Polyhedron
1 publication, 2.27%
Nano Today
Nano Today, 1, 2.27%
Nano Today
1 publication, 2.27%
Seminars in Immunology
Seminars in Immunology, 1, 2.27%
Seminars in Immunology
1 publication, 2.27%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 1, 2.27%
Journal of Drug Delivery Science and Technology
1 publication, 2.27%
ChemistrySelect
ChemistrySelect, 1, 2.27%
ChemistrySelect
1 publication, 2.27%
Biomacromolecules
Biomacromolecules, 1, 2.27%
Biomacromolecules
1 publication, 2.27%
RSC Advances
RSC Advances, 1, 2.27%
RSC Advances
1 publication, 2.27%
APL Bioengineering
APL Bioengineering, 1, 2.27%
APL Bioengineering
1 publication, 2.27%
F1000Research
F1000Research, 1, 2.27%
F1000Research
1 publication, 2.27%
Dentistry, 1, 2.27%
Dentistry
1 publication, 2.27%
Chinese Chemical Letters
Chinese Chemical Letters, 1, 2.27%
Chinese Chemical Letters
1 publication, 2.27%
Journal of Drug Targeting
Journal of Drug Targeting, 1, 2.27%
Journal of Drug Targeting
1 publication, 2.27%
1
2
3
4
5

Citations by publishers

2
4
6
8
10
12
14
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 13, 29.55%
Multidisciplinary Digital Publishing Institute (MDPI)
13 publications, 29.55%
Elsevier
Elsevier, 12, 27.27%
Elsevier
12 publications, 27.27%
American Chemical Society (ACS)
American Chemical Society (ACS), 3, 6.82%
American Chemical Society (ACS)
3 publications, 6.82%
Frontiers Media S.A.
Frontiers Media S.A., 3, 6.82%
Frontiers Media S.A.
3 publications, 6.82%
Springer Nature
Springer Nature, 3, 6.82%
Springer Nature
3 publications, 6.82%
Wiley
Wiley, 2, 4.55%
Wiley
2 publications, 4.55%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 2.27%
Royal Society of Chemistry (RSC)
1 publication, 2.27%
American Institute of Physics (AIP)
American Institute of Physics (AIP), 1, 2.27%
American Institute of Physics (AIP)
1 publication, 2.27%
F1000 Research
F1000 Research, 1, 2.27%
F1000 Research
1 publication, 2.27%
IntechOpen, 1, 2.27%
IntechOpen
1 publication, 2.27%
Taylor & Francis
Taylor & Francis, 1, 2.27%
Taylor & Francis
1 publication, 2.27%
2
4
6
8
10
12
14
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Houthoofd S. et al. Photodynamic therapy for atherosclerosis. The potential of Indocyanine Green. // Photodiagnosis and Photodynamic Therapy. 2020. Vol. 29. p. 101568.
GOST all authors (up to 50) Copy
Houthoofd S., Vuylsteke M., Mordon S., Fourneau I. Photodynamic therapy for atherosclerosis. The potential of Indocyanine Green. // Photodiagnosis and Photodynamic Therapy. 2020. Vol. 29. p. 101568.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.pdpdt.2019.10.003
UR - https://doi.org/10.1016%2Fj.pdpdt.2019.10.003
TI - Photodynamic therapy for atherosclerosis. The potential of Indocyanine Green.
T2 - Photodiagnosis and Photodynamic Therapy
AU - Houthoofd, Sabrina
AU - Vuylsteke, M.
AU - Mordon, S.
AU - Fourneau, Inge
PY - 2020
DA - 2020/03/01 00:00:00
PB - Elsevier
SP - 101568
VL - 29
SN - 1572-1000
ER -
BibTex
Cite this
BibTex Copy
@article{2020_Houthoofd,
author = {Sabrina Houthoofd and M. Vuylsteke and S. Mordon and Inge Fourneau},
title = {Photodynamic therapy for atherosclerosis. The potential of Indocyanine Green.},
journal = {Photodiagnosis and Photodynamic Therapy},
year = {2020},
volume = {29},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016%2Fj.pdpdt.2019.10.003},
pages = {101568},
doi = {10.1016/j.pdpdt.2019.10.003}
}
Found error?